Raman is also a member of the Johns Hopkins Kimmel Cancer Center. “We first had to determine whether DDX3 was expressed in ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously ...

Breast cancer can spread to your bones, lungs, liver, and brain, among other parts of your body. In a 2020 study of 414,528 people with breast cancer, 5,185 people (1.25%) developed metastatic ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown ...

Their findings hold promise for advancing the development of preclinical tools to predict breast cancer bone metastasis.

Future Oncol. 2010;6(1):55-74. Stimulates proliferation, migration and invasiveness of breast cancer cells SPRYCEL Phase III trials recruiting for CML Phase I/II (+ZA) recruit Important for proper ...

Their findings hold promise for advancing the development of preclinical tools to predict breast cancer bone metastasis. Researchers from Tampere University, Finland, and Izmir Institute of ...

After determining that breast cancer bone metastasis cells had high levels of DDX3, the research team turned to mice to test if RK-33 had any effect on the DDX3 protein and function of the cancer ...

The average time from consultation to treatment for bone metastases decreased by almost 4 days with virtual simulation ...

Their findings hold promise for advancing the development of preclinical tools to predict breast cancer bone metastasis. Breast cancer is a significant global public health challenge, with 2.3 million ...

Intravenous; mCRPC: Metastatic castration-resistant prostate cancer; P: Placebo ... the incidence of skeletal-related events (SREs) in bone metastatic CRPC (mCRPC). Denosumab compared with ...

In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis).RK-33 was previously ...